# Stemcyte, Inc.

- Location (FDA's records): Baldwin Park, CA
- FDA decisions: 2 (2022–2024): 2 510(k) clearances
- Product codes: FRO (2)
- Predicates its devices cite: 2 (1 its own); citations of its devices by later devices: 2 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Valeant Pharmaceuticals: 1 (https://510kreport.com/company/valeant-pharmaceuticals)

## Firms that cite its devices most
- Oneness Biotech Co., Ltd.: 1 (https://510kreport.com/company/oneness-biotech)

## Its most-cited devices
- K232655: Bonvadis® (2024), cited by 1
- K212554: Bonvadis Topical Cream (2022), cited by 1

## Recent decisions
- K232655: Bonvadis® (May 22, 2024)
- K212554: Bonvadis Topical Cream (Aug 19, 2022)

Source page: https://510kreport.com/company/stemcyte